Literature DB >> 17609325

The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen.

Yongjun Tian1, Yang Xu, Zhenhua Zhang, Zhongji Meng, Li Qin, Mengji Lu, Dongliang Yang.   

Abstract

The major hydrophilic region (MHR) of hepatitis B surface antigen (HBsAg) harbors conformational B-cell epitopes and is the major target of neutralizing antibodies to HBsAg (anti-HBs). Mutant HBsAg (mtHBsAg) with amino acid substitutions such as G145R is known to affect the binding of specific anti-HB antibodies and their detection by conventional diagnostic assays. In the present study, we focused on the role of the amino acid positions 120 to 123, which are around MHR 2 according to the spectrum of recently identified, naturally occurring mtHBsAg. Strikingly, the amino acid substitution K122I abolished the reactivity of HBsAg in all immunoassays tested so far. Also, mtHBsAg G145R could be clearly detected with four different enzyme-linked immunosorbent assays that were based on monoclonal anti-HB antibodies (MAbs) with high affinity. Positive immunofluorescence staining of mtHBsAg K122I was achieved only by polyclonal anti-HBs, while all MAbs tested failed. mtHBsAg T123N showed a low reactivity in immunoassays and appeared to be secretion defective. The amino acid substitution P120T reduced the binding of anti-HBs but did not completely prevent the detection of mtHBsAg by anti-HB MAbs. The testing of naturally occurring mtHBsAg confirmed that the presence of amino acid substitutions within the region of 120 to 123 is strongly associated with impaired detection in immunoassays. In conclusion, MHR 2 is essential for HBsAg antigenicity, a fact that has not been recognized before.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609325      PMCID: PMC2045265          DOI: 10.1128/JCM.00508-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.

Authors:  Xin Zheng; Reinhold Schirmbeck; Gero Hilken; Jennifer A Waters; Dongliang Yang; Jörg Reimann; Michael Roggendorf; Mengji Lu
Journal:  Virology       Date:  2002-03-15       Impact factor: 3.616

2.  Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen.

Authors:  S Seddigh-Tonekaboni; J A Waters; S Jeffers; R Gehrke; B Ofenloch; A Horsch; G Hess; H C Thomas; P Karayiannis
Journal:  J Med Virol       Date:  2000-02       Impact factor: 2.327

3.  Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays.

Authors:  J H Ireland; B O'Donnell; A A Basuni; J D Kean; L A Wallace; G K Lau; W F Carman
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

4.  Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.

Authors:  Georges Abou Jaoudé; Camille Sureau
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants.

Authors:  K Hino; Y Katoh; E Vardas; J Sim; K Okita; W F Carman
Journal:  Vaccine       Date:  2001-07-16       Impact factor: 3.641

6.  Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers.

Authors:  J Hou; Z Wang; J Cheng; Y Lin; G K Lau; J Sun; F Zhou; J Waters; P Karayiannis; K Luo
Journal:  Hepatology       Date:  2001-11       Impact factor: 17.425

Review 7.  Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.

Authors:  M P Cooreman; G Leroux-Roels; W P Paulij
Journal:  J Biomed Sci       Date:  2001 May-Jun       Impact factor: 8.410

8.  High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

Authors:  K M Weinberger; T Bauer; S Böhm; W Jilg
Journal:  J Gen Virol       Date:  2000-05       Impact factor: 3.891

9.  Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein.

Authors:  C M Mangold; R E Streeck
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  A unique insertion in the S gene of surface antigen--negative hepatitis B virus Chinese carriers.

Authors:  J Hou; P Karayiannis; J Waters; K Luo; C Liang; H C Thomas
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

View more
  32 in total

1.  Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance.

Authors:  Chunchen Wu; Wanyu Deng; Liu Deng; Liang Cao; Bo Qin; Songxia Li; Yun Wang; Rongjuan Pei; Dongliang Yang; Mengji Lu; Xinwen Chen
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.

Authors:  Kazuhiko Takeda; Mari Maruki; Takahiro Yamagaito; Machiko Muramatsu; Yasuhiro Sakai; Hiroaki Tobimatsu; Hironori Kobayashi; Yoshiteru Mizuno; Yukio Hamaguchi
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

3.  HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.

Authors:  Timothy Na Archampong; Ceejay L Boyce; Margaret Lartey; Kwamena W Sagoe; Adjoa Obo-Akwa; Ernest Kenu; Jason T Blackard; Awewura Kwara
Journal:  Antivir Ther       Date:  2016-05-11

4.  Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients.

Authors:  Golnaz Bahramali; Majid Sadeghizadeh; Samad Amini-Bavil-Olyaee; Seyed-Moayed Alavian; Abbas Behzad-Behbahani; Ahmad Adeli; Mohammad-Reza Aghasadeghi; Safieh Amini; Fereidoun Mahboudi
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 5.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

6.  A new vaccine escape mutant of hepatitis B virus causes occult infection.

Authors:  Qing Ye; Shi-Qiang Shang; Wei Li
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 7.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

8.  A new splice variant of the major subunit of human asialoglycoprotein receptor encodes a secreted form in hepatocytes.

Authors:  Jia Liu; Bin Hu; Yan Yang; Zhiyong Ma; Yuan Yu; Shenpei Liu; Baoju Wang; Xiping Zhao; Mengji Lu; Dongliang Yang
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

9.  Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains.

Authors:  Samad Amini-Bavil-Olyaee; Mihael Vucur; Tom Luedde; Christian Trautwein; Frank Tacke
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  Molecular characteristics of occult hepatitis B virus from blood donors in southeast China.

Authors:  Quan Yuan; Shan-Hai Ou; Chang-Rong Chen; Sheng-Xiang Ge; Bin Pei; Qing-Rui Chen; Qiang Yan; Yong-Cai Lin; Hong-Ying Ni; Cheng-Hao Huang; Anthony E T Yeo; James W K Shih; Jun Zhang; Ning-Shao Xia
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.